Figure 2

(A) Body weight is significantly reduced in HCV patients with genotype 1 following 48 weeks of antiviral treatment. No significant decline was present in the control group during the observation period. For all figures, the initial measurements are depicted as light grey and the follow-up measurements are depicted as dark grey blots. (B) Body fat is significantly decreased in HCV patients following antiviral regimens - irrespective of genotype or duration of therapy. No alterations were observed within the control group. (C) A significant reduction in body cell mass was also observed in both HCV groups post-therapy. Again, no significant alterations were present in the therapy-naïve group.